A study on tumor cell/cell interactions using mouse mammary tumor models
A study on tumor cell/cell interactions using mouse mammary tumor models
批准号:
08671337
负责人:
TAKEDA Yasutaka
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997
中文摘要
从可移植的激素依赖性小鼠乳腺肿瘤TPDMT-4(T4)中,通过不同条件传代,建立了自主亚系T4- o1320(320)和T4- o196(96)。这些自主肿瘤在DDD初代小鼠中生长迅速,而亲代T4未生长。在三维胶原凝胶培养中,320个细胞与T4一样形成了类似于正常乳腺的支状或星状结构,但有96个细胞呈圆形团块状,呈结节状,形态完全不同。然后将320和96个细胞分别单独培养或胶原酶解离后共培养,观察肿瘤细胞/细胞之间是否存在生长速率和形态上的相互作用。但单培养与共培养的差异不明显,说明技术有待改进。因此,我们研究了这些细胞之间甲基化肽的存在是否不同。这种金属结合蛋白是研究肿瘤细胞异质性的一个候选因子,据报道与抗肿瘤药物的耐药性有关。用免疫组织学方法对该蛋白进行了研究。在恶性程度较低的亚肿瘤中,该蛋白水平较低。甲基甲氧胺似乎是研究肿瘤细胞恶性和异质性的有用因子。该体外系统在人类乳腺癌中的应用正在进行中。
英文摘要
The autonomous sublines, T4-O1320(320)and T4-O196(96), were established from the transplantable hormone-dependent mouse mammary tumor, TPDMT-4(T4), by passaging under different conditions. These autonomous tumors were characterized by rapid growth in DDD virgin mice and the parental T4 by no growth in them. In three-dimensional collagen gel culture, 320 cells formed branched or stellate structures similar to normal mammary glands as did T4, but 96 cells grew as rounded masses with knobs and showed completely different morphology. Then, 320 and 96 cells were cultured separately or co-cultured after collagenase dissociation to determine whether there are tumor cell/cell interaction on the growth rate and morphology. However, significant differences between single-culture and co-culture were not investigated on them, showing the necessity of improvement of the technology. Therefore, we studied whether the presence of methallotionein are different or not between these cells. This metal-binding protein, a candidate factor to be investigated relative to heterogeneity of tumor cells, is reported to associate with resistance of anti-tumor drugs. This protein was studied by immuno-histological methods. It was observed that the protein level was the lower in the less malignant subline tumors. Methallotionein seems to be a useful factor to investigate malignancy and heterogeneity of tumor cells. Application of this in vitro system to human breast cancer is in progress.
期刊论文(29)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Shimizu M., Yamamoto A., Nakano H., and Matsuzawa A.: "Augmentation of antitumor immunity with bacterial superantigen Staphylococca1 enterotoxin B-bound tumor cells." Cancer Res.56. 3731-3736 (1996)
Shimizu M.、Yamamoto A.、Nakano H. 和 Matsuzawa A.:“利用细菌超抗原葡萄球菌 1 肠毒素 B 结合肿瘤细胞增强抗肿瘤免疫力。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shimizu, M., Yamamoto, A., Nakano, H., and Matsuzawa, A.: "Augmentation of antitumor immunity with bacterial superantigen staphylococcal enterotoxin B-bound tumor cells." Cancer Res.56. 3731-3736 (1996)
Shimizu, M.、Yamamoto, A.、Nakano, H. 和 Matsuzawa, A.:“利用细菌超抗原葡萄球菌肠毒素 B 结合肿瘤细胞增强抗肿瘤免疫力。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kizu R., Takeda Y.et a1: "An orally active antitumor cyclohexanediamine-Pt(IV)comp1ex:trans,cis,cis-bis(n-valerato)(oxalato)(1R,2R-cyclohexanediamin)Pt(IV)" Anti-cancer Drugs. 7. 248-256 (1996)
Kizu R.、Takeda Y.et a1:“一种口服活性抗肿瘤环己烷二胺-Pt(IV)comp1ex:反式,顺式,顺式-双(n-戊酸)(草酸)(1R,2R-环己烷二胺)Pt(IV)”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shimizu M.,Yamamoto T.,Nagata S.and Matsuzawa A.: "A trial to kill tumor cells through Fas(CD95) mediated apoptosis in vivo." Biophys.Res.Commun.228. 375-379 (1996)
Shimizu M.、Yamamoto T.、Nagata S. 和 Matsuzawa A.:“通过 Fas (CD95) 介导的体内细胞凋亡杀死肿瘤细胞的试验。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Matsuzawa A.and Takeda Y.: "Estabhshment of tumor dorment state following clinically complete cure of disseminated leukemin by chemotherapy in mice." In “Premalignancy and Tumor Dormancy"eds.R.H.Schenermann and E.Yefenof.R.G.Landes Company, 15 (1996)
Matsuzawa A. 和 Takeda Y.:“在小鼠中通过化疗临床完全治愈播散性白血病后建立肿瘤休眠状态”,R.H.Schenermann 和 E.Yefenof.R.G.Landes Company 编辑,15(1996 年) )
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 29 条
Basic study for Analysis of Intractable Resistant Tumor Cells and their Overcoming in Cancer Gene Therapy
-
批准号:14571125
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2002
-
负责人:TAKEDA Yasutaka
-
依托单位:
Clinical Application of Tumor-specific Anti-tumor Immunity Induced by Tumor Cells Expressing Fas (CD95) Ligand
-
批准号:13557097
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$8.83万
-
财政年份:2001
-
负责人:TAKEDA Yasutaka
-
依托单位:
Basic study for. Cancer Gene Therapy by Antitumor Effects Using Fas-Fas Ligand-Mediated Apoptosis
-
批准号:12671144
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.11万
-
财政年份:2000
-
负责人:TAKEDA Yasutaka
-
依托单位:
A study for cancer gene therapy through Fas-mediated apoptosis
-
批准号:10671099
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:1998
-
负责人:TAKEDA Yasutaka
-
依托单位:
Study of Tumor Progression in vivo and in vitro using
-
批准号:06671186
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1994
-
负责人:TAKEDA Yasutaka
-
依托单位:
海外基金